Prof. Young said, “Doing so would set back development by another 12 or so months, and while this is a tough decision to take, the urgent need for a vaccine has to be everyone’s priority.”
With the latest development, Australia will order an extra 20 million units from AstraZeneca and 11 million from Novovax.
A vaccine needs to hurdle three stages of trials before it can then be considered for approval for public use.
Australia has yet to grant approval to a COVID-19 vaccine candidate.
As of this posting, Australia’s total COVID-19 cases climbed to 28,000 with 9 new cases recorded.
—————————————-
Have a story you want USA Herald to cover? Submit a tip here and if we think it’s newsworthy, we’ll follow up on it.
Want to contribute a story? We also accept article submissions – check out our writer’s guidelines here.
